141 related articles for article (PubMed ID: 14652795)
21. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.
Comi G
Clin Ther; 2009 Jun; 31(6):1142-57. PubMed ID: 19695384
[TBL] [Abstract][Full Text] [Related]
22. Plasma S100beta and NSE levels and progression in multiple sclerosis.
Koch M; Mostert J; Heersema D; Teelken A; De Keyser J
J Neurol Sci; 2007 Jan; 252(2):154-8. PubMed ID: 17187827
[TBL] [Abstract][Full Text] [Related]
23. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
24. [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis].
Sailer M; Fazekas F; Gass A; Kappos L; Radue EW; Rieckmann P; Toyka K; Wiendl H; Bendszus M
Rofo; 2008 Nov; 180(11):994-1001. PubMed ID: 18937154
[TBL] [Abstract][Full Text] [Related]
25. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
Zivadinov R; Leist TP
J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
[TBL] [Abstract][Full Text] [Related]
26. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy.
Ehrlich S; Haas J; Zipp F; Infante-Duarte C
J Neurol Sci; 2007 Jan; 252(1):83-7. PubMed ID: 17169375
[TBL] [Abstract][Full Text] [Related]
28. Spinal cord imaging in multiple sclerosis.
Tench CR; Morgan PS; Jaspan T; Auer DP; Constantinescu CS
J Neuroimaging; 2005; 15(4 Suppl):94S-102S. PubMed ID: 16385022
[TBL] [Abstract][Full Text] [Related]
29. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
Zivadinov R
Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
[TBL] [Abstract][Full Text] [Related]
30. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
[TBL] [Abstract][Full Text] [Related]
31. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
Rovira A; León A
Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis of multiple sclerosis].
Yang CC
Acta Neurol Taiwan; 2005 Dec; 14(4):213-20. PubMed ID: 16425550
[TBL] [Abstract][Full Text] [Related]
33. The use of MRI as an outcome measure in clinical trials.
Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D
Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836
[TBL] [Abstract][Full Text] [Related]
34. Defining interferon beta response status in multiple sclerosis patients.
Rudick RA; Lee JC; Simon J; Ransohoff RM; Fisher E
Ann Neurol; 2004 Oct; 56(4):548-55. PubMed ID: 15389896
[TBL] [Abstract][Full Text] [Related]
35. Neopterin in HIV-1 infection.
Wirleitner B; Schroecksnadel K; Winkler C; Fuchs D
Mol Immunol; 2005 Feb; 42(2):183-94. PubMed ID: 15488607
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis: disease biomarkers as indicated by pathophysiology.
Berger T; Reindl M
J Neurol Sci; 2007 Aug; 259(1-2):21-6. PubMed ID: 17367811
[TBL] [Abstract][Full Text] [Related]
37. A calculation method for semi automatic follow up of multiple sclerosis by magnetic resonance eco planar perfusion imaging.
Placidi G; Sabatini M; Gallucci M; Sotgiu A
Stud Health Technol Inform; 2003; 95():164-9. PubMed ID: 14663981
[TBL] [Abstract][Full Text] [Related]
38. The role of MRI in the diagnosis of multiple sclerosis.
Traboulsee AL; Li DK
Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831
[TBL] [Abstract][Full Text] [Related]
39. beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosis.
Bagnato F; Zivadinov R; Cecchinelli D; Tancredi A; Grop A; Pierallini A; De Lena C; Prencipe M; Reale G; Zorzon M; Millefiorini E
Eur J Neurol; 2004 Jul; 11(7):455-60. PubMed ID: 15257683
[TBL] [Abstract][Full Text] [Related]
40. Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodies.
Santos R; Weinstock-Guttman B; Tamaño-Blanco M; Badgett D; Zivadinov R; Justinger T; Munschauer F; Ramanathan M
J Neuroimmunol; 2006 Jul; 176(1-2):125-33. PubMed ID: 16698090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]